Literature DB >> 4119694

The nature of adrenergic mechanisms involved in anaphylatoxin activity in the guinea-pig.

R Hicks, A C Sackeyfio.   

Abstract

1. Evidence is presented to elucidate the nature of the adrenergic mechanisms involved in responses of the guinea-pig to anaphylatoxin (AT).2. Investigation by means of adrenalectomy, adrenergic neurone blockade, alpha- and beta- adrenoceptor blockade and exclusion of autonomic reflexes, revealed that the adrenergic mechanisms provoked included catecholamine release from the adrenal medulla, sympathetic reflex activity, stimulation of adrenergic neurones and alpha- and beta-adrenoceptor activity.3. The cardiovascular effects of AT, mediated by histamine release, were largely attributable to adrenal medullary and adrenergic neuronal mechanisms. These mechanisms also exerted a restraint on the predominantly histamine mediated bronchoconstrictor effect of AT.4. The cardiovascular effects of AT activity, not attributable to histamine release, were also probably associated with catecholamine release. However, the bronchoconstrictor component of this AT activity was not significantly affected by guanethidine, and it would, therefore, appear that neuronal bronchodilator mechanisms did not exert a restraint upon this aspect of AT activity.5. These findings are generally compatible with previous work showing that adrenergic mechanisms operate during AT-induced responses. In contrast to previous reports, however, the adrenergic activity was predominantly associated with the effects of released histamine.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4119694      PMCID: PMC1666333          DOI: 10.1111/j.1476-5381.1972.tb06871.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Effect of drugs on the uptake and metabolism of H3-norepinephrine.

Authors:  G HERTING; J AXELROD; L G WHITBY
Journal:  J Pharmacol Exp Ther       Date:  1961-11       Impact factor: 4.030

2.  Blockade of the actions of adrenaline and noradrenaline.

Authors:  M NICKERSON
Journal:  Pharmacol Rev       Date:  1959-06       Impact factor: 25.468

3.  Activation of a histamine-releasing agent (anaphylatoxin) in normal rat plasma.

Authors:  A M ROTHSCHILD; M ROCHA E SILVA
Journal:  Br J Exp Pathol       Date:  1954-10

4.  Contributions to the physiology of the lungs: Part I. The bronchial muscles, their innervation, and the action of drugs upon them.

Authors:  W E Dixon
Journal:  J Physiol       Date:  1903-03-16       Impact factor: 5.182

5.  Actions of anaphylatoxin on circulation and respiration of the guinea pig.

Authors:  G Bodammer; W Vogt
Journal:  Int Arch Allergy Appl Immunol       Date:  1967

6.  Release of catecholamines in the guinea-pig by substances involved in anaphylaxis.

Authors:  P J Piper; H O Collier
Journal:  Nature       Date:  1967-02-25       Impact factor: 49.962

Review 7.  The release and fate of vaso-active hormones in the circulation.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

8.  Definition of the histaminic component of the bronchoconstrictor and cardiovascular effects of anaphylatoxin in the guinea-pig.

Authors:  A C Sackeyfio
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

9.  Contraction of the guinea-pig ileum induced by anaphylatoxin independent of histamine release.

Authors:  G Bodammer; W Vogt
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

10.  QUANTITATIVE EVALUATION OF GUINEA-PIG ANAPHYLAXIS IN VIVO.

Authors:  R HICKS; G D LEACH
Journal:  Br J Pharmacol Chemother       Date:  1963-12
View more
  2 in total

1.  Proceedings: A comparison of the histopathological effects of anaphylatoxin (AT) and prostaglandins E2 (PGE2) and F2alpha (PGF2alpha) in guinea-pig lungs.

Authors:  A C Sackeyfio
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Effects of the C5a anaphylatoxin and its relationship to cyclo-oxygenase metabolites in rabbit vascular strips.

Authors:  T E Hugli; F Marceau
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.